A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above

Clinical trial NCT05144139 · COMPLETED

Trial details

NCT number: NCT05144139
Sponsor: Stemirna Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

COVID-19 Pandemic

Start date: 2021-12-03
Primary completion: 2022-08-28
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.